Insights on the Faropenem Sodium Global Market to 2026 - Featuring Alkem Laboratories, Kopran and Trumac Healthcare Among Others'

DUBLIN, Dec. 17, 2021 /PRNewswire/ -- The 'Faropenem Sodium Market Research Report by Product, Type, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19' report has been added to ResearchAndMarkets.com's offering.

The Global Faropenem Sodium Market size was estimated at USD 167.78 million in 2020, is expected to reach USD 182.38 million in 2021, and projected to grow at a CAGR of 9.03% reaching USD 281.99 million by 2026. Market Statistics

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Competitive Strategic Window

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Faropenem Sodium Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Company Usability Profiles

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Faropenem Sodium Market, including Alkem Laboratories Ltd., Canagen Pharmaceuticals Inc, DGpeptides Co., Ltd., Glentham Life Sciences Ltd, Hangzhou Verychem Science and Technology Co., Ltd., Huanggang LUBAN Pharmaceutical Co., Ltd, Hunan Warrant Chiral Pharmaceutical Co., Ltd, Kopran Ltd, Lunan Pharmaceutical Group, MANUS AKTTEVA BIOPHARMA LLP, Merck KGaA, NIKSAN HEALTHCARE, Rezcrit Healthcare, Shandong Chenlong Pharmaceutical Co., Ltd, Shaoxing Hantai Pharmaceutical Co.Ltd, Shop RX Pharmacy, Shree Nath Life Sciences Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Trumac Healthcare, and Viraj Pharmaceuticals Pvt. Ltd. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Faropenem Sodium Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Faropenem Sodium Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Faropenem Sodium Market?4. What is the competitive strategic window for opportunities in the Global Faropenem Sodium Market?5. What are the technology trends and regulatory frameworks in the Global Faropenem Sodium Market?6. What is the market share of the leading vendors in the Global Faropenem Sodium Market?7. What modes and strategic moves are considered suitable for entering the Global Faropenem Sodium Market? Key Topics Covered: 1. Preface 2. Research Methodology 3. Executive Summary 4. Market Overview 4.1. Introduction4.2. Cumulative Impact of COVID-19 5. Market Dynamics 5.1. Introduction5.2. Drivers5.2.1. Increase in the prevalence of bacterial infections 5.2.2. Rising use for the treatment of upper and lower respiratory infections, urinary tract infection, and skin infections5.3. Restraints5.3.1. Side effects of Faropenem sodium tablets5.4. Opportunities5.4.1. New product development and process improvement5.4.2. Continuous research and development driven by the emergence of microbial resistance5.5. Challenges5.5.1. Risk of development of cross-resistance 6. Faropenem Sodium Market, by Product 6.1. Introduction6.2. Purity:97%-99%6.3. Purity:>99% 7. Faropenem Sodium Market, by Type 7.1. Introduction7.2. Injection Product7.3. Table Product 8. Americas Faropenem Sodium Market 8.1. Introduction8.2. Argentina8.3. Brazil8.4. Canada8.5. Mexico8.6. United States 9. Asia-Pacific Faropenem Sodium Market 9.1. Introduction9.2. Australia9.3. China9.4. India9.5. Indonesia9.6. Japan9.7. Malaysia9.8. Philippines9.9. Singapore9.10. South Korea9.11. Taiwan9.12. Thailand 10. Europe, Middle East & Africa Faropenem Sodium Market 10.1. Introduction10.2. France10.3. Germany10.4. Italy10.5. Netherlands10.6. Qatar10.7. Russia10.8. Saudi Arabia10.9. South Africa10.10. Spain10.11. United Arab Emirates10.12. United Kingdom 11. Competitive Landscape 11.1. FPNV Positioning Matrix11.1.1. Quadrants11.1.2. Business Strategy11.1.3. Product Satisfaction11.2. Market Ranking Analysis11.3. Market Share Analysis, by Key Player11.4. Competitive Scenario11.4.1. Merger & Acquisition11.4.2. Agreement, Collaboration, & Partnership11.4.3. New Product Launch & Enhancement11.4.4. Investment & Funding11.4.5. Award, Recognition, & Expansion 12. Company Usability Profiles 12.1. Alkem Laboratories Ltd.12.2. Canagen Pharmaceuticals Inc.12.3. DGpeptides Co., Ltd.12.4. Glentham Life Sciences Ltd.12.5. Hangzhou Verychem Science and Technology Co., Ltd.12.6. Huanggang LUBAN Pharmaceutical Co., Ltd.12.7. Hunan Warrant Chiral Pharmaceutical Co., Ltd.12.8. Kopran Ltd.12.9. Lunan Pharmaceutical Group12.10. MANUS AKTTEVA BIOPHARMA LLP12.11. Merck KGaA12.12. NIKSAN HEALTHCARE12.13. Rezcrit Healthcare12.14. Shandong Chenlong Pharmaceutical Co., Ltd.12.15. Shaoxing Hantai Pharmaceutical Co.Ltd.12.16. Shop RX Pharmacy12.17. Shree Nath Life Sciences Pvt. Ltd.12.18. Sun Pharmaceutical Industries Ltd.12.19. Trumac Healthcare12.20. Viraj Pharmaceuticals Pvt. Ltd. 13. Appendix For more information about this report visit

Media Contact:

Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

MENAFN17122021003732001241ID1103389825